Skandinaviska Enskilda Banken (SEB)’s St Jude Medical STJ Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-46,322	Closed	-$3.71M	–	765
2016 Q4	$3.71M	Buy	46,322 +185	+0.4%	+$14.7K	0.04%	278
2016 Q3	$3.68M	Buy	46,137 +200	+0.4%	+$16.1K	0.04%	311
2016 Q2	$3.58M	Sell	45,937 -2,200	-5%	-$157K	0.04%	316
2016 Q1	$2.65M	Sell	48,137 -1,400	-3%	-$76.3K	0.03%	359
2015 Q4	$3.06M	Buy	+49,537	New	+$3.12M	0.04%	289

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s STJ Position: Q1 2017 in Review

Skandinaviska Enskilda Banken (SEB) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 46,322 shares — an estimated $3.71M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in STJ in Q4 2015 and held it in 5 quarters. The position peaked at $3.71M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Skandinaviska Enskilda Banken (SEB) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 46,322 St Jude Medical shares in Q1 2017, an estimated $3.71M.
Skandinaviska Enskilda Banken (SEB) first reported a position in St Jude Medical in Q4 2015 and held it in 5 quarters.
Skandinaviska Enskilda Banken (SEB)'s St Jude Medical position peaked at $3.71M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2017, filed 15 May 2017.